Navigation Links
Growth Achieved in Spherix's Health Sciences Consulting Business
Date:11/29/2007

Phase 3 Clinical Trial on Track, Market Research Contracts Signed

BELTSVILLE, Md., Nov. 29 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX) has recently signed contracts to provide technical and regulatory consulting services to several major consumer, food, ingredient, and pharmaceutical companies. Spherix's Health Sciences Consulting Division provides scientific and strategic support for suppliers, manufacturers, distributors, and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products, and industrial chemicals and pesticides.

"I am very pleased with the progress made in our Health Sciences Division," said Claire Kruger, CEO and Director of Health Sciences of Spherix. "Revenues earned through these efforts will add to our substantial cash reserve, and will be very useful moving forward."

The Company further reported that its Phase 3 clinical trial of Naturlose(R) as a treatment for Type 2 diabetes is progressing on schedule. Since moving the entire study to the United States, patient recruitment has increased and, logistically, everything is moving ahead much more efficiently. The protocol for the Company's dose ranging study has been finalized and is scheduled to begin later this year. An additional study to determine if Naturlose will work with only one dose per day is being finalized, and it is hoped that this study will begin early next year. Results from a recent trial evaluating efficacy of tagatose in toothpaste that was conducted at the University of Maryland did not show significant activity; further trials for this endpo
'/>"/>

SOURCE Spherix Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
2. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
3. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
4. NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models
5. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
8. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
10. Tone Deafness Explained, from the Harvard Health Letter
11. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 Levi & Korsinsky ... in the United States District Court for the District ... investors who purchased Galectin Therapeutics Inc. ("Galectin" or the ... July 28, 2014. For more information, click ... that during the Class Period the Company violated federal ...
(Date:8/28/2014)... , August 28, 2014 ... "DNA diagnostics Market (products, applications, techniques, end users ... Growth and Forecast, 2013 - 2020," indicates that ... billion by 2020 registering a CAGR of 9.8% ... accurate diagnosis and cost effectiveness over alternative diagnostic ...
(Date:8/28/2014)... /PRNewswire-iReach/ -- Gateway Analytical announced today that they ... Annual Global Pharma Manufacturing Summit in ... The Global Pharma Manufacturing Summit offers a networking ... biologic pharmaceutical manufacturing. The conference is focused on ... such as the increasing pressure to grow and ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3
... May 6, 2011 CryoLife, Inc. (NYSE: ... tissue processing company, today announced the final results of ... owned subsidiary CL Falcon, Inc., for 49.9 percent of ...  The tender offer expired at 12:00 midnight, Eastern Time, ...
... Ferring Pharmaceuticals Inc., the makers of FIRMAGON® (degarelix for injection), ... the race to end prostate cancer as an official sponsor ... growing men,s health event series in the United States. Now ... (GPCC) is led by ZERO – The Project to ...
Cached Medicine Technology:CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation 2CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation 3CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation 4CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation 5CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation 6Ferring Pharmaceuticals to Support Great Prostate Cancer Challenge® Events Across the Country in National Effort to End Prostate Cancer 2Ferring Pharmaceuticals to Support Great Prostate Cancer Challenge® Events Across the Country in National Effort to End Prostate Cancer 3
(Date:8/28/2014)... sleep not only puts teens at risk for poor grades, ... warn. The study authors analyzed data collected from more ... Nearly one-fifth of them got less than six hours of ... group was 20 percent more likely to be obese at ... of sleep per night at age 16, the investigators found. ...
(Date:8/28/2014)... wing? Did they fall from trees and learn to flap ... the ground and pump their "arms" to get aloft? , ... but a new University of California, Berkeley, study provides a ... to maneuver in midair, a talent that could have helped ... perch. , The study looked at how baby birds, in ...
(Date:8/28/2014)... August 28, 2014 NJ Top ... of North Jersey. , NJ Top Doc, Dr. ... now a certified medical examiner for the department ... by the department to perform all drug testing ... in diagnosing and treating musculoskeletal disorders including disk ...
(Date:8/28/2014)... 28, 2014 (BRONX, NY) Researchers from Albert ... institutions have developed a potential antibody therapy for Sudan ebolavirus ... A different strain, the Zaire ebolavirus (EBOV), is now devastating ... Ebola outbreaks (most recently in 2012) that have ... reported in ACS Chemical Biology . , Between ...
(Date:8/28/2014)... Aug. 28, 2014 In 2012, The ... in grants for two groundbreaking brain cancer research ... One of those projects has officially received the ... Francisco, which means patient enrollment for the trial ... "Genomics Enabled Medicine in Glioblastoma Trial," TGen and ...
Breaking Medicine News(10 mins):Health News:Less Sleep in Teen Years Tied to More Pounds at 21 2Health News:Flapping baby birds give clues to origin of flight 2Health News:Flapping baby birds give clues to origin of flight 3Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 2Health News:NJ Top Docs Presents Dr. Christophe Oliveira of Rehabilitation Instiute of North Jersey 3Health News:Drug shows promise against Sudan strain of Ebola in mice 2Health News:TGen receives approval for patient enrollment in brain cancer clinical trial 2
... and CHICAGO, Jan. 14 Aon ... advisor, released today a preliminary forecast of direct ... Ponzi scheme.(Logo: http://www.newscom.com/cgi-bin/prnh/20041215/CGW049LOGO )"While the maximum ... over $6 billion, the range of direct insured ...
... who want a baby, study says, , , WEDNESDAY, Jan. 14 (HealthDay ... vitro fertilization have up to an 86 percent chance of giving ... the odds are less than 50 percent -- in some cases, ... infertility, and it can overcome most causes of infertility for those ...
... Chaka Fattah (D-PA) issues the following statement upon passage by ... by a bipartisan vote of 289 to 139. ... to bring change to Washington by expanding health care for ... today. I have joined with more than two-thirds of my ...
... treatment of liver disease, study says , , WEDNESDAY, Jan. 14 ... not appear to help Hispanic whites with the liver disease ... suggests. , This is second major ethnic group -- the ... the therapy, consisting of pegylated interferon with ribavirin, in recent ...
... is being adopted in the U.S. and around the world, ... simple checklist that ensures everyone in the operating room is ... report. , The need for improving safety in surgery is ... each year, 60 million of them in the United States. ...
... National Council of Legislators from Gaming States ( ... states with casinos and other forms of state-regulated ... encouraging states to take action to make all ... NCLGS 2009 Winter Meeting, held last weekend in ...
Cached Medicine News:Health News:Aon Benfield Forecasts Potential Impact on the Insurance Industry Resulting From the Alleged Madoff Scandal 2Health News:IVF Treatments Often Work for Women Under 35 2Health News:IVF Treatments Often Work for Women Under 35 3Health News:Hispanics Respond Poorly to Standard Hepatitis C Therapy 2Health News:Surgeon's Checklist Saves Lives 2Health News:Surgeon's Checklist Saves Lives 3Health News:National Council of Legislators From Gaming States Adopts Resolution Supporting 100% Smokefree Gaming Venues 2
... The Devex Mesh System is indicated for ... a diseased vertebral body resected or excised for ... of the spinal cord and neural tissues, and ... body. Devex Mesh System is also indicated for ...
... Ocelot stackable cage system provides anterior column ... total vertebrectomies from T1 to L5. The ... Carbon fiber polymer cages that are stacked ... needs. The Peek Carbon fiber reinforced polymer ...
... Vitoss engineered to resemble ... and structure. -TCP constructs ... in spinal arthrodesis surgery ... due to trauma and ...
... system provides anterior column support for single ... T1 to L5. The system consists of ... cages that are stacked to a desired ... Carbon fiber reinforced polymer material emulates the ...
Medicine Products: